fluo-3 has been researched along with Osteosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexis, MN; Consoulas, C; Katopodis, H; Kletsas, D; Konstantinidou, E; Koutsilieris, M; Manoussakis, M; Pitulis, N; Poyatzi, A; Tenta, R; Tiblalexi, D | 1 |
| Ferrier, J; Yu, H | 1 |
2 other study(ies) available for fluo-3 and Osteosarcoma
| Article | Year |
|---|---|
Mechanisms of the action of zoledronic acid on human MG-63 osteosarcoma cells.
Topics: Aniline Compounds; Apoptosis; Calcium; Cell Differentiation; Cell Division; Cell Line, Tumor; Diphosphonates; Doxorubicin; Edetic Acid; Flow Cytometry; Fluorescent Dyes; G1 Phase; Humans; Imidazoles; Osteosarcoma; Polyisoprenyl Phosphates; ras Proteins; Receptors, Estrogen; Resting Phase, Cell Cycle; Reverse Transcriptase Polymerase Chain Reaction; Sesquiterpenes; Xanthenes; Zoledronic Acid | 2008 |
Osteoblast-like cells have a variable mixed population of purino/nucleotide receptors.
Topics: Adenosine Triphosphate; Aniline Compounds; Calcium; Fluorescent Dyes; Humans; Microscopy, Fluorescence; Osteoblasts; Osteosarcoma; Receptors, Purinergic; Thionucleotides; Tumor Cells, Cultured; Uridine Triphosphate; Xanthenes | 1993 |